1. Home
  2. TPST vs WYY Comparison

TPST vs WYY Comparison

Compare TPST & WYY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • WYY
  • Stock Information
  • Founded
  • TPST 2011
  • WYY 1991
  • Country
  • TPST United States
  • WYY United States
  • Employees
  • TPST N/A
  • WYY N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • WYY EDP Services
  • Sector
  • TPST Health Care
  • WYY Technology
  • Exchange
  • TPST Nasdaq
  • WYY Nasdaq
  • Market Cap
  • TPST 33.0M
  • WYY 33.6M
  • IPO Year
  • TPST N/A
  • WYY 1998
  • Fundamental
  • Price
  • TPST $7.44
  • WYY $3.19
  • Analyst Decision
  • TPST Hold
  • WYY Strong Buy
  • Analyst Count
  • TPST 3
  • WYY 1
  • Target Price
  • TPST $30.00
  • WYY $7.00
  • AVG Volume (30 Days)
  • TPST 234.4K
  • WYY 81.2K
  • Earning Date
  • TPST 08-07-2025
  • WYY 08-13-2025
  • Dividend Yield
  • TPST N/A
  • WYY N/A
  • EPS Growth
  • TPST N/A
  • WYY N/A
  • EPS
  • TPST N/A
  • WYY N/A
  • Revenue
  • TPST N/A
  • WYY $142,582,209.00
  • Revenue This Year
  • TPST N/A
  • WYY $10.84
  • Revenue Next Year
  • TPST N/A
  • WYY $12.37
  • P/E Ratio
  • TPST N/A
  • WYY N/A
  • Revenue Growth
  • TPST N/A
  • WYY 24.03
  • 52 Week Low
  • TPST $5.35
  • WYY $2.19
  • 52 Week High
  • TPST $30.03
  • WYY $6.25
  • Technical
  • Relative Strength Index (RSI)
  • TPST 56.13
  • WYY 43.21
  • Support Level
  • TPST $7.06
  • WYY $3.21
  • Resistance Level
  • TPST $7.18
  • WYY $3.46
  • Average True Range (ATR)
  • TPST 0.28
  • WYY 0.19
  • MACD
  • TPST 0.03
  • WYY 0.02
  • Stochastic Oscillator
  • TPST 93.18
  • WYY 32.14

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

Share on Social Networks: